Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Rosacea Market Size Changed, over the years?
In the past few years, the rosacea market has experienced significant growth. It is set to intensify from $1.95 billion in 2024 to $2.15 billion in 2025, reflecting a compound annual growth rate of 9.9%. The past growth is attributable to increased awareness about rosacea, improved healthcare accessibility, growth in disposable incomes, as well as government backing for rosacea research and treatments.
How Much Will the Rosacea Market Be Worth in 2029?
The market for rosacea is anticipated to witness robust expansion in the upcoming years, reaching a valuation of $3.02 billion in 2029 with an 8.9% compound annual growth rate (CAGR). This growth during the projected period can be traced back to factors such as biologic therapies, the rise in demand for personalized medicine, an aging populace, and an uptick in comorbidities prevalence. Key trends shaping this forecast period include a shift towards minimally invasive and non-invasive rosacea treatments, the emergence of digital health technologies, rosacea-specific cosmetics, and non-invasive therapeutic approaches.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12945&type=smp
Which is the Largest Company in the Rosacea Market?
Major companies operating in the rosacea market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Galderma S.A., Dr. Reddy’s Laboratories Ltd., Lupin Limited, LEO Pharma A/S, Almirall S.A., Supernus Pharmaceuticals Inc., Taro Pharmaceuticals, Mayne Pharma, Aclaris Therapeutics Inc., Sol-Gel Technologies Ltd., Nestle Skin Health S.A., Foamix Pharmaceuticals.
What Are the Main Market Drivers in the Rosacea Industry?
The rosacea market’s expansion is anticipated to be fuelled by the escalating number of skin diseases. Medical conditions that alter the skin’s look, structure, and function are referred to as skin diseases, and can impact the skin, hair, nails, and associated tissues. Various fungal infections, including Candida overgrowth, can lead to rosacea, a kind of inflammation and skin problem. Additionally, rosacea is linked with a statistically substantial increased risk of skin cancers like hepatic cancer, non-melanoma skin cancer, and breast cancer. As an example, Cancer Research UK, a UK-based cancer research institution, predicted in February 2023 that new annual melanoma skin cancer cases in the UK will rise from nearly 20,800 cases in 2023-2025 to roughly 26,500 cases in 2038-2040. This equates to an anticipated 9% increase in melanoma incidence rates, which is anticipated to reach 33 cases per 100,000 people per year by 2038-2040. Therefore, the rising prevalence of skin diseases is causing the rosacea market to grow. The growth of the rosacea market is expected to be bolstered by the growing use of telehealth. Telehealth, also known as healthcare telecommunications, uses digital technologies and communication tools to offer remote healthcare services, consultations, monitoring, and education. Patients can receive medical care, consultations, and support from healthcare providers without needing to make in-person visits. The increasing use of telehealth is a significant factor in enhancing rosacea care. It improves accessibility to care, allows for early intervention, and promotes patient education and adherence. For example, the Office of the Assistant Secretary for Planning and Evaluation, a US government department, reported in April 2023 that during the study period, adults’ use of telehealth ranged from 20.5% to 24.2%, averaging 22% in the last four weeks of 2022. However, the use was significantly lower amongst uninsured individuals (9.4%), young adults aged 18-24 (17.6%), and those residing in the Midwest (18.7%). Therefore, the rosacea market’s expansion is being fueled by the increasing use of telehealth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12945&type=smp
How Is the Rosacea Market Segments Structured?
The rosacea market covered in this report is segmented –
1) By Type: Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea
2) By Drug Class: Antibiotics, Alpha Agonists, Retinoid, Corticosteroids, Immunosuppressants, Other Drug Classes
3) By Mode of Administration: Topical, Oral
4) By End-User: Hospitals, Clinics, Retail pharmacies, Online pharmacies
Subsegments:
1) By Erythematotelangiectatic Rosacea: Persistent Facial Redness, Visible Blood Vessels
2) By Papulopustular Rosacea: Red Bumps, Pus-Filled Pimples
3) By Ocular Rosacea: Eye Irritation, Inflammation Of Eyelids, Dry Eyes
4) By Phymatous Rosacea: Rhinophyma, Thickened Skin On The Face
What Strategic Trends Are Transforming the Rosacea Market?
Major firms in the rosacea market are consolidating their resources to innovate new products and maintain their market significance. For example, Galderma S.A., a pharmaceutical company based in Switzerland, introduced in June 2022, EPSOLAY cream; a unique topical treatment with microencapsulated benzoyl peroxide (E-BPO). It has been scientifically validated to alleviate rosacea-induced bumps and discolorations. EPSOLAY Cream employs Sol-Gel Technology’s exclusive patented method to encapsulate benzoyl peroxide within a silica-based microcapsule, creating a protective barrier between the skin surface and the medication. This consequently reduces the irritation and dryness typically associated with standard benzoyl peroxide treatments.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/rosacea-global-market-report
Which Global Regions Offer the Highest Growth in the Rosacea Market?
North America was the largest region in the rosacea market in 2024. Asia-Pacific is expected to the fastest-growing region in the forecast period. The regions covered in rosacea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12945
This Report Delivers Insight On:
1. How big is the rosacea market, and how is it changing globally?
2. Who are the major companies in the rosacea market, and how are they performing?
3. What are the key opportunities and risks in the rosacea market right now?
4. Which products or customer segments are growing the most in the rosacea market?
5. What factors are helping or slowing down the growth of the rosacea market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model